Delivery Order SPE2DX22D0010-SPE2D825FHA85
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency Medical Supply Chain on July 18, 2025, with a ceiling value of $3,498.66 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger $999.9 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026. The award carries no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2.27M by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical and medical supply provision to federal defense healthcare systems. The award is a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $31,793.84 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $426,923.79 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, which was competitively awarded with no set-aside designation, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $46,446.88 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with an ultimate completion date of April 11, 2025. This non-competitive delivery order (Contract No. 4567865120) represents a child award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $55,168.29 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with an ultimate completion date of April 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $818,162.77 from the Defense Logistics Agency's Medical Supply Chain division on July 18, 2025. This firm fixed-price delivery order, which is not associated with a set-aside program, is scheduled for completion by July 21, 2025, with performance taking place at the contractor's Conshohocken facility. The delivery order represents a child contract action under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,704.06 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025. This firm fixed-price, non-set-aside contract is classified as a child order under a larger indefinite delivery contract vehicle and is scheduled for completion by July 21, 2025. The award represents a routine pharmaceutical supply delivery supporting federal...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $4,945.86 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHA85Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $1,015.00 by the Defense Logistics Agency Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle, SPE2DX, valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for the Defense Logistics Agency Troop Support Medical operations. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a strategic partner in maintaining pharmaceutical supply chains for federal medical and military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/18/25 |